U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Science & Research
  3. About Science & Research at FDA
  4. FDA Grand Rounds
  5. FDA Grand Rounds: Identification of Persistent Organic Pollutants in Foods: Method Development and Automation - 04/13/2023
  1. FDA Grand Rounds

Webcast | Virtual

Event Title
FDA Grand Rounds: Identification of Persistent Organic Pollutants in Foods: Method Development and Automation
April 13, 2023

Date:
April 13, 2023
Time:
12:00 PM - 1:00 PM ET
Image
FDA Grand Rounds April23 - 1600x900

About the Speaker   

Jeffrey C. Archer, M.S.
Arkansas Human and Animal Food Laboratory 
Office of Regulatory Affairs 
U.S. Food and Drug Administration

Jeff Archer began his career in the Persistent Organic Pollutants (POPs) field with the U.S. Environmental Protection Agency in 1991 after receiving his M.S. in Chemistry from Oklahoma State University.  After moving to the Office of Regulatory Affairs at the U.S. Food & Drug Administration in 2001, he became a National Expert in the POPs field where he focused on streamlining POP methods and data processing.  Jeff has received multiple awards for his contributions within the POPs program including the EPA Bronze Medal for Commendable Service and the FDA Award of Merit for Exceptional Leadership.

About the Presentation

The gold standard for the determination of legacy Persistent Organic Pollutants (POPs) which includes polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), polychlorinated biphenyls (PCBs), and polybrominated diphenyl ethers (PBDEs) had not significantly evolved for over 40 years.  In this presentation, the new instrumentation, extraction procedures, as well as novel data processing and evaluations used in an accredited laboratory will be discussed.  Similar streamlined methodologies and software processes are now being evaluated for per- and polyfluorinated alkyl substances (PFAS) determinations in an accredited laboratory.

Learning Objectives

  • Describe the criteria for work completed in an accredited laboratory.
  • Recognize the benefits and limitations of using direct isotope dilution.

Webcast Recording

https://fda.zoomgov.com/rec/share/796N3jgpOf3y2fkPbhkCD0Wd3cHk_DqxltSjvROn-5QsKgthkGAKwgGmH4HZRVvI.xJK5GfOvlYk8gJsH

Event Materials

Activity Announcement for FDA Grand Rounds – April 13, 2023

Back to Top